Subscribe for the latest news and events
Most Popular
Improving Everolimus Safety in Oncology: Missed Opportunities in Risk Minimization
Targeting the ‘Don’t Eat Me’ Signal: The Future of Macrophage Checkpoint Inhibitors
A New Era in Liver Disease: FDA Approves First Medication 'Rezdiffra' for NASH
Zongertinib Gains FDA Accelerated Approval for HER2+ NSCLC with 75% ORR
FDA Approves Wegovy to Reduce Risk of Heart Problems in Obese Adults
Exploring the Transformative Power of AI in Drug Discovery: A report by S&P Global
NETTER-2 Trial: Lutathera Cuts Risk of Death by 72% in Neuroendocrine Tumor Treatment
EpCAM-Targeting ADC CX-2051 Shows Promising Efficacy in Advanced Colorectal Cancer
FDA Grants Accelerated Approval to Semaglutide for MASH with Liver Fibrosis
Transformative One-Time Gene Therapy: FDA Approves Pfizer's BEQVEZ, for Hemophilia B
Bayer Poised for Landmark Year with Blockbuster Treatment Advances Across Key Diseases
New Horizon in Food Allergy Treatment: FDA Approves Xolair for All Ages
FDA Approves Groundbreaking CAR T Cell Therapy, Abecma, for Multiple Myeloma
FDA Approves Carvykti as Targeted CAR-T Cell Therapy for Multiple Myeloma
Novartis and Legend Biotech Strike $1 Billion Deal on CAR-T Therapy for Lung Cancer
